146 results about "Cyclic compound" patented technology

Disclosed is a liquid crystal composition. The liquid crystal composition includes liquid crystal molecules including at least one of a liquid crystal compound having an alkenyl group and a liquid crystal compound having an alkoxy group, and a first stabilizer including a compound having a structure represented by Formula 1:where n is 0 or 1; m is 0 or 1; k is 0 or 1; Z1, Z2, and Z3 are each independently a single bond, —C═C—, —OCO—, —COO—, —CF2O—, or a C1 to C5 alkylene group; X1, X2, X3, and X4 are each independently hydrogen or halogen; Y is hydrogen, an alkylene group, an alkoxy group, a hydroxyl group, —NHCOCH3, or ═O; and A and B are cyclic compounds.

An etchant composition includes hydrogen peroxide, a carboxylic acid-based compound, a fluorine-based compound, and a nitrogen-based cyclic compound. The hydrogen peroxide is included in an amount of 0.001 to 4 wt %. Additionally or alternatively, the weight ratio between the fluorine-based compound and the nitrogen-based cyclic compound is 1:0.01 to 1:3.

The invention discloses a synthesis method of 9-dichloromethylene-5-amino-benzonorbornene and an intermediate product, the synthesis method comprises the following steps: firstly, synthesizing a cyclization compound 1 as shown in a formula 1 from a cold solution of 6, 6-dichlorofulvene and 1, 4-benzoquinone under the action of a solution of a catalyst I, carrying out oximation reaction on the cyclization compound 1 prepared in the step a and hydroxylamine salt under an alkaline condition, and carrying out post-treatment to obtain the 9-dichloromethylene-5-amino-benzonorbornene. Under the action of a catalyst II, adding the oximate 2 prepared in the step b into a closed container, carrying out hydrogenation reduction to obtain 9-dichloromethylene-5-amino-benzo norbornene, and directly treating the reduction product with acid to obtain 9-dichloromethylene-5-amino-benzo norbornene, namely the 9-dichloromethylene-5-amino-benzo norbornene, namely the 9-dichloromethylene-5-amino-benzo norbornene. According to the method, the cyclization compound is oximated firstly, then the residual carbonyl and two double bonds on the ring are subjected to one-step reduction through catalytic hydrogenation, the working procedure is optimized, meanwhile, reduction by using expensive sodium borohydride is avoided, the method is short in synthesis route and suitable for industrialization, and the production cost is reduced.

The application provides a cyclic imide derivative with a high-efficiency multi-exciton effect and a synthesis method and application thereof, and belongs to the technical field of organic optoelectronic materials. The cyclic imide derivative has any one of the following structural formulae: wherein n is 1 or 2 or 3; m is an integer in 1-15; Ar represents an aryl group; and R is selected from a substituted or unsubstituted C1-C15 alkyl chain or a phenyl chain. The application directly synthesizes a novel cyclic compound through a synthesis method, and a series of different cyclic imide compounds can be further synthesized by changing the number of aryl groups on the ring and the type of imide compounds. Experimental tests prove that the cyclic imide compound can be applied in the field of singlet fission materials, and excellent bipolar transport performance is exhibited when the cyclic imide compound is applied in an organic field effect transistor device, so the cyclic imide compound has a good industrial application prospect.

To provide a substituted heterocyclic fused cyclic compound having a novel structure, which is used as a selective inhibitor for KRAS mutations and has the advantages of high activity, good selectivity, low toxicity and side effects, etc.SOLUTION: The present invention relates to a substituted heterocyclic fused cyclic compound as represented by formula (I) or formula (IA) and having a selective inhibitory effect on KRAS gene mutation, or a pharmaceutically-acceptable salt, a stereoisomer, a solvate or a prodrug thereof, a pharmaceutical composition containing the compound, and an application thereof to the preparation of cancer drugs.SELECTED DRAWING: None

The present disclosure relates generally to materials including cyclic compounds that are adhesive below the temperature at which pyrolysis occurs, and which are also adhesive at higher temperatures including the temperatures used in the regime for growing SiC crystals, which may be above 2000° C, or for SiC or GaN epitaxy, which may be above 1500° C.

The application discloses a synthesis method of aza-cyclic modified hydroxyalkyl diethanolamine borate linking agent, which comprises the following steps: (1) adding hydroxyalkyl diethanolamine and boric acid into a three-neck flask provided with a stirrer, a thermometer and a vacuum distillation device, and stirring and heating to react until no water is generated; (2) adding an aza-cyclic compound into the reaction system obtained in the step (1), increasing the reaction temperature, and removing water generated in the reaction by vacuum distillation when no water vapor is generated, so as to obtain a target product. The borate linking agent obtained by the synthesis method has good hydrolysis resistance, and when the borate linking agent is used in a hydroxyl-terminated solid propellant, the mechanical properties of the hydroxyl-terminated solid propellant can be effectively improved.

A compound represented by formula (I). The compound has good agonistic activity on an APJ receptor, can effectively inhibit the production of cAMP, has weak ability to recruit β-arrestin, and has good pharmacokinetic properties.

Disclosed are a composition for removing edge beads from a metal-containing resist or a metal-containing resist developer composition, and a method of forming or providing a pattern using the composition or the developer composition. The composition for removing edge beads from a metal-containing resist or the developer composition of a metal-containing resist may include: a cyclic compound including in a ring at least one heteroatom selected from N, O, and S and at least two carbonyl groups; and a solvent.

The invention discloses a lithium ion battery electrolyte based on a chalcogenide cyclic compound, a preparation method of the lithium ion battery electrolyte and a ternary lithium ion battery. The lithium ion battery electrolyte comprises an organic solvent system, a lithium salt system and an additive system, the organic solvent system comprises at least one cyclic carbonate and at least one chain carbonate; the additive system comprises a chalcogenide cyclic compound, and the chalcogenide cyclic compound has the following structural formula; an X group is selected from any one of the following groups; wherein the Y group, the Y1 group and the Y2 group are respectively and independently selected from any one of halogen, alkyl, alkenyl, alkynyl, aryl, alkoxy, amino, silicon group and carboxyl; according to the invention, the cycle life of the ternary lithium ion battery can be effectively prolonged, the cycle performance of the ternary lithium ion battery (especially an NCM622 ternary lithium ion battery) can be obviously enhanced, and the service life of the ternary lithium ion battery can be obviously prolonged.

A drug delivery system delivers a cyclic compound to a target cell or tissue while suppressing the pharmacological activity of the cyclic compound. A complex includes the cyclic compound and a delivery carrier having a shaft portion for carrying the cyclic compound. The shaft portion is complexed by inclusion in the cyclic compound to form a host-guest complex.

Provided is a novel photothermal conversion material. A manganese oxide cluster compound represented by general formula (1). (In general formula (1), L is a tricarboxytriptycene residue, alpha1 is an organic acid residue, beta1 is a solvent selected from the group consisting of water and a polar organic solvent having a dielectric constant of 6-47, P1 is a coordinating molecule selected from the group consisting of a nitrogen-containing heterocyclic compound, an oxygen-containing cyclic compound and a phosphine, or a polymer containing the coordinating molecule, [gamma] 1 is a solvent selected from water and a polar organic solvent having a dielectric constant of 6-47, q is a number of 0 < = m < = 8, and m is a number of 0 < = m < = 10. ).

Provided is an etchant composition including, about 3.0 wt % to about 15.0 wt % of ammonium persulfate, about 0.1 wt % to about 5.0 wt % of an inorganic acid, about 0.1 wt % to about 2.0 wt % of a fluorine-containing ammonium salt, about 0.01 wt % to about 1.5 wt % of a chlorine-containing ammonium salt, about 0.1 wt % to about 2.0 wt % of a 2-nitrogen cyclic compound, about 0.1 wt % to about 2.0 wt % of a 4-nitrogen cyclic compound, about 0.1 wt % to about 3.0 wt % of an aminosulfonic acid, and a remainder of water such that the total weight of the entire etchant composition becomes 100 wt %, wherein the weight ratio of the 4-nitrogen cyclic compound to the 2-nitrogen cyclic compound is in a range of about 1.6 to about 5.0.

A condensed cyclic compound represented by Formula 1, a light-emitting device including the condensed cyclic compound, and an electronic apparatus including the light-emitting device:wherein Formula 1 is as described herein.

Provided are a condensed cyclic compound represented by Formula 1, an organic light-emitting device including the condensed cyclic compound represented by Formula 1, and an electronic apparatus, wherein the description of substituents of Formula 1 are as described herein.

Disclosed is an etching liquid composition having excellent etching performance. According to one aspect, there is provided an etching liquid composition comprising: hydrogen peroxide; a phosphate; an amine having at least one or more hydroxyl groups; a fluoride; a tetraazacyclic compound having four nitrogen atoms within the ring; and a triazacyclic compound having three nitrogen atoms within the ring, and the weight ratio of the tetraazacyclic compound to the triazacyclic compound is 1:0.01 or more to 1:1.25 or less.

Solvent-based compositions for post-etch residue removal and related methods are provided. The composition comprises a first amine halide component. The composition comprises a second amine halide component. The composition comprises a hydrogen halide component. The composition comprises an organic solvent. The organic solvent comprises a cyclic compound having at least one electron-withdrawing substituent. The organic solvent does not comprise at least one of N-methyl-2-pyrrolidone, dimethylacetamide, or any combination thereof. The first amine halide component, the second amine halide component, the hydrogen halide component, and the organic solvent are present in an amount sufficient for the composition to remove a substance at an etch rate of at least 50 Angstroms / min.

The present invention provides a hetero-cyclic compound, an organic light emitting device including the same, and a composition for an organic material layer.SOLUTION: The present invention relates to a hetero-cyclic compound represented by Chemical Formula 1, and an organic light emitting device and a composition for an organic material layer comprising the same. The definition of each substituent in Formula 1 is the same as described in the description of the invention.SELECTED DRAWING: Figure 1

The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.

This application discloses a method for synthesizing chiral cyano-containing full-carbon quaternary cyclic compounds, characterized by the following steps: mixing a solvent, an oxidant, an alkynyl malononitrile compound, a carboxylic acid compound, a palladium salt, and a chiral dinitrogen ligand; reacting the mixture; drying; and separating to obtain the chiral cyano-containing full-carbon quaternary cyclic compound. This method can achieve a palladium-catalyzed tandem reaction of alkynyl malononitrile with a carboxylic acid involving asymmetric acyl oxidative cyclization / acyl migration, yielding cyano-containing full-carbon quaternary cyclic compounds with optical purity in good yields (enantiomer ratios up to 96.5:3.5). This invention features a broad substrate range, readily available raw materials, simple and practical operation, and mild reaction conditions.

Provided are cyclic peptidomimetics that can, e.g., antagonize the extracellular domain of EGFR, and methods of use thereof.

This polyester depolymerization method includes subjecting a polyester to a depolymerization reaction in the presence of an alcohol and a homogeneous iron catalyst. The depolymerization reaction is preferably carried out in the presence of an additive, and the additive is preferably at least one selected from the group consisting of a nitrogen atom-containing cyclic compound or pyrimidine, imidazole and benzimidazole. The homogeneous iron catalyst is preferably at least one selected from the group consisting of iron (III) chloride (FeCl3), iron (III) bromide (FeBr3), and iron (III) iodide (FeI3).

[Problem] To perform selective hydrogenolysis of a cyclic compound that has a five-membered ring structure and that is included in a saturated cyclic compound used as a hydrogen carrier. [Solution] A metal catalyst used in hydrogenolysis of a cyclic compound that has a five-membered ring structure and that is included in a saturated cyclic compound used as a hydrogen carrier, comprises: a silica-based carrier as a catalyst carrier; and iridium or rhodium as a metal supported on the catalyst carrier.

Provided are a light-emitting device including a condensed cyclic compound represented by Formula 1, an electronic apparatus including the light-emitting device, and the condensed cyclic compound represented by Formula 1. A light-emitting device includes a first electrode; a second electrode facing the first electrode; an interlayer between the first electrode and the second electrode, the interlayer including an emission layer; and the condensed cyclic compound represented by Formula 1:

Embodiments provide an etchant composition that includes about 5.0 to about 20.0 wt % of a persulfate, about 0.01 to about 15.0 wt % of a sulfonic acid, about 0.01 to about 2.0 wt % of a fluorine compound, about 0.01 to about 5.0 wt % of a 4-nitrogen cyclic compound, about 0.01 to about 1.0 wt % of an amino acid including a hydrophobic group having at least two carbon atoms, and water A weight ratio of the amino acid to the 4-nitrogen cyclic compound is in a range of about 1:16 to about 1:60.

This invention discloses a heat-resistant polymer, its preparation method, and the application of cyclic imide diol compounds, belonging to the field of polymer materials. The polymer comprises a segment (I) containing a cyclic imide, a segment (II) containing a cyclic compound, and an optional third segment (III); wherein the segment (I) containing the cyclic imide can improve the heat resistance of the polymer, and its structure is such that R1 is a residue of an easily cyclized diacid, and R2 is a residue of an amino-containing diol. The heat-resistant polymer of this invention has improved heat resistance and good mechanical properties.

Disclosed is a method for producing a compound library comprising two or more cyclic compounds represented by the formula (I), comprising a step of allowing a macrocyclase in vitro to act on two or more peptides represented by the formula (II): LP-X—(Xa)m-Y—Z (II) wherein X represents a group represented by the formula (1), Y is a peptide residue consisting of four amino acids and / or analogs thereof and contains a group represented by the formula (2) (wherein R1 and B1 are as defined above, and R3 represents a hydrogen or a hydrocarbon group), and LP is present or absent and, when present, represents a peptide residue consisting of 1 to 100 amino acids and / or analogs thereof, and forming the nitrogen-containing 6-membered ring A while eliminating LP, if present, to form the two or more cyclic compounds represented by the formula (I).

The application provides a chemical ring-closing construction method of a cyclic compound library and the cyclic compound library, which is synthesized by using a solid carrier, a molecule containing a photo-cleavable group, a connecting molecule, a synthetic building block and a ring-closing end molecule at one end. The method of the application has mild ring-closing conditions and stronger universality, and expands the chemical reaction type of the coded compound library and the diversity space of the compound library.